FDA approves Telix's Pixclara as first PET imaging drug for glioma
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) announced that the U.S. Food and Drug Administration has approved its New Drug ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

